1,191
Views
3
CrossRef citations to date
0
Altmetric
Review

Assessing efficacy in myelofibrosis treatment: a focus on JAK inhibition

&
Pages 631-641 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

T. Devos, P. Zachée, D. Bron, L. Noens, J. Van Droogenbroeck, P. Mineur, Y. Beguin, Z. Berneman, F. S. Benghiat, A. Kentos, C. Chatelain, H. Demuynck, J. Lemmens, K. Van Eygen, K. Theunissen, F. Trullemans, P. Pierre, W. Pluymers & L. Knoops. (2015) Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica 70:2, pages 105-111.
Read now
Lucy Liu, Nicolas Gaboriaud, Konstantina Vougogianopoulou, Yan Tian, Jun Wu, Wei Wen, Leandros Skaltsounis & Richard Jove. (2014) MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biology & Therapy 15:2, pages 178-184.
Read now

Articles from other publishers (1)

Ruben A. Mesa, Yun Su, Adrien Woolfson, Josef T. Prchal, Kathleen Turnbull, Elias Jabbour, Robyn Scherber, Alan L. Shields, Meaghan Krohe, Funke Ojo, Farrah Pompilus, Joseph C. Cappelleri & Claire Harrison. (2019) Development of a symptom assessment in patients with myelofibrosis: qualitative study findings. Health and Quality of Life Outcomes 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.